Hexagon Bio

Home - Hexagon

Menlo Park, United States · Founded 2017 · $185.3M raised

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$185.3M
Last Round
$77.3M Series CFeb 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Hexagon Bio is a biopharmaceutical company developing novel antibody-drug conjugate (ADC) payloads for oncology. Its proprietary natural products platform mines cytotoxic small molecules from microbial genomes using data science, genomics, synthetic biology, and automation to identify next-generation ADC payloads that overcome resistance to existing therapies and expand indication space.

Summary

Hexagon Bio is a Biotech company based in Menlo Park, United States, founded in 2017. It has raised $185.3M in total across 3 rounds, most recently a $77.3M Series C round in Feb 2023.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CFeb 2023
$77.3M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hexagon Bio on Indexed.vc
<a href="https://indexed.vc/companies/hexagon-bio"><img src="https://indexed.vc/api/badge/company/hexagon-bio" alt="Hexagon Bio on Indexed.vc" width="260" height="76" /></a>